NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/03/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.53 mln
Float2.96 mln
Earnings Date11/12/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.47
Reliable
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.05
Debt-free
Pre-Tax Margin
-43,127%
Severely loss-making
ROE
-78.55
Deeply negative
Business Description
Cardio Diagnostics Holdings Inc. is a Chicago-based company founded in 2017 that creates blood tests and digital tools to help doctors identify and manage heart disease risk. Its products use genetic and epigenetic data to give clinicians a clearer picture of a patient's cardiovascular health, supporting earlier and more informed treatment decisions. The company works with telemedicine services, specialty medical practices, and employers, and also offers research solutions to help pharmaceutical companies develop new heart disease treatments.
